Vanguard Group’s Aardvark Therapeutics, Inc. Common Stock AARD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.23M Buy
460,977
+295,486
+179% +$3.99M ﹤0.01% 3134
2025
Q1
$1.24M Buy
+165,491
New +$1.24M ﹤0.01% 3648